Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Ubiquitin ligase ARF-BP1/Mule modulates base excision repair.

The EMBO journal | Oct 21, 2009

http://www.ncbi.nlm.nih.gov/pubmed/19713937

Base excision repair (BER) is the major cellular pathway involved in removal of endogenous/spontaneous DNA lesions. Here, we study the mechanism that controls the steady-state levels of BER enzymes in human cells. By fractionating human cell extract, we purified the E3 ubiquitin ligase Mule (ARF-BP1/HectH9) as an enzyme that can ubiquitylate DNA polymerase beta (Pol beta), the major BER DNA polymerase. We identified lysines 41, 61 and 81 as the major sites of modification and show that replacement of these lysines to arginines leads to increased protein stability. We further show that the cellular levels of Pol beta and its ubiquitylated derivative are modulated by Mule and ARF and siRNA knockdown of Mule leads to accumulation of Pol beta and increased DNA repair. Our findings provide a novel mechanism regulating steady-state levels of BER proteins.

Pubmed ID: 19713937 RIS Download

Mesh terms: Blotting, Western | Comet Assay | DNA Polymerase beta | DNA Repair | Electrophoresis, Polyacrylamide Gel | HeLa Cells | Humans | Protein Binding | RNA Interference | Ubiquitin-Conjugating Enzymes | Ubiquitin-Protein Ligases | Ubiquitination

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: Cancer Research UK, Id: 10339
  • Agency: Cancer Research UK, Id: 8971
  • Agency: Medical Research Council, Id: G0501068
  • Agency: Medical Research Council, Id: G0700730
  • Agency: Cancer Research UK, Id:
  • Agency: Medical Research Council, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.